Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
No participants developed antibodies against AOD-9604, and no treatment-related serious adverse events led to study withdrawal
Because AOD 9604 was engineered to isolate a specific fragment of the HGH molecule, its proposed mechanism and its considerations differ from secretagogues that stimulate the bodys own growth hormone release
Because of this targeted structure, it is discussed in research in the context of fat metabolism rather than the broader effects of full growth hormone
The Clinical Trial Foundation: Six Controlled Studies Between 2001 and 2006, AOD-9604 underwent rigorous clinical evaluation through six separate trials designed to assess both efficacy and safety
US$ 26.53
US$ 26.07
US$ 21.66
